Your browser doesn't support javascript.
loading
Phase 1b trial of docetaxel, prednisone, and pazopanib in men with metastatic castration-resistant prostate cancer.
George, Daniel J; Halabi, Susan; Healy, Patrick; Barak, Ian; Winters, Carolyn; Anand, Monika; Wilder, Rhonda; Klein, Melissa; Martinez, Elia; Nixon, Andrew B; Harrison, Michael R; Szmulewitz, Russell; Armstrong, Andrew J.
Afiliação
  • George DJ; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina.
  • Halabi S; Division of Medical Oncology, Department of Medicine, Duke University, Durham, North Carolina.
  • Healy P; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina.
  • Barak I; Department of Biostatistics, Duke University, Durham, North Carolina.
  • Winters C; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina.
  • Anand M; Department of Biostatistics, Duke University, Durham, North Carolina.
  • Wilder R; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina.
  • Klein M; Department of Biostatistics, Duke University, Durham, North Carolina.
  • Martinez E; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina.
  • Nixon AB; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina.
  • Harrison MR; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina.
  • Szmulewitz R; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina.
  • Armstrong AJ; Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, Illinois.
Prostate ; 79(15): 1752-1761, 2019 11.
Article em En | MEDLINE | ID: mdl-31497882
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Sulfonamidas / Prednisona / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias de Próstata Resistentes à Castração / Docetaxel Tipo de estudo: Prognostic_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Revista: Prostate Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Sulfonamidas / Prednisona / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias de Próstata Resistentes à Castração / Docetaxel Tipo de estudo: Prognostic_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Revista: Prostate Ano de publicação: 2019 Tipo de documento: Article